greeksoup/ stock research

Xeris Biopharma Holdings, Inc. 13F holders

240 funds reported a position in Xeris Biopharma Holdings, Inc. in their 13F for the quarter ended 30 June 2026, together 108.3 million shares worth $857.7 million. Against the quarter before, 30 opened a position, 105 added, 65 trimmed and 28 sold out; together they bought a net 2.2 million shares. The largest holders: BlackRock, Inc., D. E. Shaw & Co., Inc. and Vanguard Capital Management LLC.

Funds holding240+3 on Q1 2026
Shares they held108.3Mworth $857.7 million
Net bought on the quarter2.2M sharesabout $17.7 million at the funds' values
Funds buying to selling135 to 93opened or added, to cut or sold
Opened 30Added 105Held 37Trimmed 65Sold out 28
Opened: 30 fundsAdded: 105 fundsHeld: 37 fundsTrimmed: 65 fundsSold out: 28 funds

What each fund did in XERS against its 13F for the quarter before; a change under 0.1% of a holding counts as held

Q3 2024: 144 funds, 64.3 million shares144Q3 2024Q4 2024: 162 funds, 66.0 million shares162Q4 2024Q1 2025: 199 funds, 87.6 million shares199Q1 2025Q2 2025: 200 funds, 90.5 million shares200Q2 2025Q3 2025: 230 funds, 97.8 million shares230Q3 2025Q4 2025: 225 funds, 100.8 million shares225Q4 2025Q1 2026: 237 funds, 105.2 million shares237Q1 2026Q2 2026: 240 funds, 108.3 million shares240Q2 2026

Funds reporting a position in XERS in their 13F, each quarter; hover a bar for the shares they held

Filed so far for the quarter to 30 September 2026

2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 26 reported a position in Xeris Biopharma Holdings, Inc.: 1 opened one, 10 added, 6 trimmed and 3 sold out, a net 880,039 shares bought.

The largest moves in the name among the funds that have filed, against each fund's previous 13F.

The well-known funds

Of the 44 funds followed here, 7 reported a position in Xeris Biopharma Holdings, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 4.7 million shares worth $37.4 million, 0.0% of its reported book. In the quarter, 2 funds added or opened a position and 4 trimmed or sold out; together they sold a net 2.0 million shares, about $16.0 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
Geode Capital Management4,718,183$37.4 million0.0%+427,554added30 June 202613F
Two Sigma Investments1,885,503$14.9 million0.0%-38,699trimmed30 June 202613F
Norges Bank797,200$6.3 million0.0%held30 June 202613F
Citadel Advisors664,564$5.3 million0.0%-17,070trimmed30 June 202613F
FMR LLC644,057$5.1 million0.0%+130,981added30 June 202613F
Millennium Management131,664$1.0 million0.0%-2,134,310trimmed30 June 202613F
Renaissance Technologies67,337$533,3080.0%-385,523trimmed30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

The largest holders

FundSharesShare of allValueOf its bookChange in sharesFiling
BlackRock, Inc.14,525,53913.41%$115.0 million0.00%+1,579,75413F
D. E. Shaw & Co., Inc.7,804,7587.20%$61.8 million0.04%+15,94713F
Vanguard Capital Management LLC7,340,2296.78%$58.1 million0.00%+359,34713F
State Street Corp.4,821,5664.45%$38.2 million0.00%+163,39213F
Geode Capital Management, LLC4,718,1834.36%$37.4 million0.00%+427,55413F
Nuveen, LLC4,385,1414.05%$34.7 million0.01%+1,468,54313F
Rosalind Advisors, Inc.2,908,9812.69%$23.0 million8.65%-322,71913F
Qube Research & Technologies Ltd2,893,7492.67%$22.9 million0.03%-1,220,67613F
Vanguard Portfolio Management LLC2,626,2082.42%$20.8 million0.00%-39,40013F
Wellington Management Group LLP2,365,1032.18%$18.7 million0.00%+193,74913F
Morgan Stanley2,337,0962.16%$18.5 million0.00%-235,55813F
Legal & General Group Plc2,012,7921.86%$15.9 million0.00%+104,50313F
Armistice Capital, LLC1,958,7021.81%$15.5 million0.43%+48,86413F
Two Sigma Investments, LP1,885,5031.74%$14.9 million0.01%-38,69913F
Parkman Healthcare Partners LLC1,807,6211.67%$14.3 million1.47%+86,35713F
Algert Global LLC1,742,9421.61%$13.8 million0.16%+585,98413F
Northern Trust Corp.1,597,7491.47%$12.7 million0.00%+153,13213F
Goldman Sachs Group Inc.1,594,0721.47%$12.6 million0.00%-19,57813F
AQR Capital Management LLC1,540,9851.42%$12.2 million0.00%+146,60913F
Charles Schwab Investment Management Inc.1,492,3671.38%$11.8 million0.00%+132,71013F
Federated Hermes, Inc.1,434,4331.32%$11.4 million0.02%+577,62013F
Bank of America Corp.1,397,0501.29%$11.1 million0.00%+522,65313F
UBS Group AG1,300,9131.20%$10.3 million0.00%-345,46513F
Ishara Investments LP1,230,0001.14%$9.7 million7.16%+205,00013F
Vanguard Fiduciary Trust Co.1,224,3981.13%$9.7 million0.00%+90,49613F
Kennedy Capital Management LLC1,209,0681.12%$9.6 million0.17%-31,62413F
Dimensional Fund Advisors LP1,073,6390.99%$8.5 million0.00%new13F
Knott David M Jr1,060,0000.98%$8.4 million4.44%no change13F
JPMorgan Chase & Co.1,058,0670.98%$8.2 million0.00%+445,58813F
Arrowstreet Capital, Limited Partnership972,8800.90%$7.7 million0.00%+839,12013F
Granahan Investment Management, LLC898,7530.83%$7.1 million0.25%-23,10113F
Norges Bank797,2000.74%$6.3 million0.00%13F
Essex Investment Management Co. LLC715,6080.66%$5.7 million0.74%-32,16113F
UBS AM, a distinct business unit of UBS Asset Management Americas LLC687,6320.63%$5.4 million0.00%+19,55813F
Voya Investment Management LLC685,5700.63%$5.4 million0.01%+60,26013F
Citadel Advisors LLC664,5640.61%$5.3 million0.00%-17,07013F
FMR LLC644,0570.59%$5.1 million0.00%+130,98113F
Walleye Capital LLC611,2960.56%$4.8 million0.03%new13F
Deutsche Bank AG529,4430.49%$4.2 million0.00%-93,56913F
Bank of New York Mellon Corp488,4410.45%$3.9 million0.00%+62,15613F
First Trust Advisors LP484,9780.45%$3.8 million0.00%new13F
IHT Wealth Management, LLC481,8710.44%$3.8 million0.08%+105,39513F
Perceptive Advisors LLC467,0130.43%$3.7 million0.06%new13F
Royce & Associates LP461,1530.43%$3.7 million0.03%+205,06613F
Man Group plc455,3800.42%$3.6 million0.01%+178,95813F
Russell Investments Group, Ltd.440,7310.41%$3.5 million0.00%+56,53613F
BNP Paribas Financial Markets430,4880.40%$3.4 million0.00%+167,70113F
State of Wisconsin Investment Board427,5130.39%$3.4 million0.01%+118,96713F
Jupiter Topco LLC414,9590.38%$3.3 million0.00%first 13F13F
Y-Intercept (Hong Kong) Ltd411,3460.38%$3.3 million0.06%+249,55313F
The 50 largest of the 240 funds that reported a position in XERS in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read moreShare of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?

Options the funds reported on XERS

FundOptionShares under the optionsValue of those sharesQuarter endedFiling
Citadel AdvisorsPuts57,800$457,77630 June 202613F
Citadel AdvisorsCalls50,200$397,58430 June 202613F
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read moreThey are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
31 July 202613GVanguard Capital Management and 1 other8.6 million5.0%30 June 2026passive, institutional (13d-1(b))EDGAR
27 March 202613G/AThe Vanguard Group and 1 other00.0%13 March 2026passive, institutional (13d-1(b))EDGAR
30 January 202613G/AThe Vanguard Group and 1 other11.2 million6.7%31 December 2025passive, institutional (13d-1(b))EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13G

Fails to deliver

Settlement dateShares failedPriceFile
30 September 2026209,157$9.98SEC
29 September 202614,179$9.83SEC
23 September 2026106$8.73SEC
8 September 202621$8.53SEC
2 September 202624$8.43SEC
18 August 2026679$8.52SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 209,157 on 30 September 2026. A fail is an operational fact about settlement, not a position.